13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001892770
Total reported value
$189.2M
$189.2M
88 檔
74.2%
The Q3 2025 SEC filing reveals that Knott David M Jr held a total portfolio value of $189.2M, covering 88 public equity positions.
Knott David M Jr executed strategic sector rebalancing during Q3 2025, establishing 22 new positions while fully exiting 18 holdings and trimming 14 positions.
In terms of portfolio concentration, the top 5 core holdings (including CLMT, APO, GOOG) accounted for 74.2% of total reported equity market value during Q3 2025.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CLMT | Calumet Inc | Stock-Other | 20.79% | — | -13.74% | |
| 2 | APO | Apollo Global Management Inc | Stock-Financials | 12.09% | -0.85% | — | |
| 3 | GOOG | Alphabet Inc-cl C | Stock-Comm Services | 11.02% | +1.46% | — | |
| 4 | JAAA | Janus Henderson Aaa Clo ETF | ETF-Other | 8.96% | -0.30% | -11.61% | |
| 5 | DAR | Darling Ingredients Inc | Stock-Consumer Staples | 3.73% | — | — | |
| 6 | XERS | Xeris Biopharma Holdings Inc | Stock-Other | 3.33% | +0.78% | -4.25% | |
| 7 | SNDX | Syndax Pharmaceuticals Inc | Stock-Other | 2.66% | -0.82% | +21.32% | |
| 8 | JPM | Jpmorgan Chase & Co | Stock-Financials | 2.59% | -0.28% | -2.91% | |
| 9 | TVTX | Travere Therapeutics Inc | Stock-Other | 2.51% | +1.93% | — | |
| 10 | ✓ | Avadel Pharmaceuticals PLC ADR | Stock-Other | 2.24% | — | -14.79% | |
| 11 | PTGX | Protagonist Therapeutics Inc | Stock-Other | 2.22% | +0.13% | +3.75% | |
| 12 | BBIO | Bridgebio Pharma Inc | Stock-Healthcare | 1.78% | -0.32% | +6.25% | |
| 13 | DCGO | Docgo Inc | Stock-Other | 1.68% | -0.27% | — | |
| 14 | VRNA | Verona Pharma PLC - Adr | Stock-Other | 1.65% | — | -30.26% | |
| 15 | LENZ | Lenz Therapeutics Inc | Stock-Other | 1.54% | -0.18% | EXIT | |
| 16 | CPRX | Catalyst Pharmaceuticals Inc | Stock-Healthcare | 1.50% | -1.77% | EXIT | |
| 17 | RZLT | Rezolute Inc | Stock-Other | 1.04% | +0.35% | — | |
| 18 | VRDN | Viridian Therapeutics Inc | Stock-Other | 1.01% | -0.35% | +27.43% | |
| 19 | CSX | Csx CORP | Stock-Industrials | 1.00% | — | — | |
| 20 | LQDA | Liquidia CORP | Stock-Other | 0.99% | — | +19.76% | |
| 21 | ✓ | Stock-Other | 0.85% | — | — | ||
| 22 | PFE | Pfizer Inc | Stock-Healthcare | 0.77% | -0.13% | — | |
| 23 | AB | Alliancebernstein Holding LP | Stock-Other | 0.74% | -0.18% | — | |
| 24 | ATRC | Atricure Inc | Stock-Other | 0.68% | -0.11% | +3.35% | |
| 25 | CYTK | Cytokinetics Inc | Stock-Healthcare | 0.66% | -0.93% | EXIT | |
| 26 | RARE | Ultragenyx Pharmaceutical In | Stock-Other | 0.63% | +0.26% | — | |
| 27 | PRAX | Praxis Precision Medicines I | Stock-Other | 0.60% | — | — | |
| 28 | RCUS | Arcus Biosciences Inc | Stock-Other | 0.52% | +0.28% | +36.00% | |
| 29 | JNJ | Johnson & Johnson | Stock-Healthcare | 0.52% | -0.06% | — | |
| 30 | CLOZ | Eldridge Bbb-b Clo ETF | ETF-Other | 0.52% | -0.06% | — | |
| 31 | BMY | Bristol-myers Squibb Co | Stock-Healthcare | 0.49% | -0.43% | — | |
| 32 | ABBV | Abbvie Inc | Stock-Healthcare | 0.47% | — | — | |
| 33 | TECX | Tectonic Therapeutic Inc | Stock-Other | 0.47% | — | — | |
| 34 | RHP | Ryman Hospitality Properties | Stock-Real Estate | 0.43% | +0.03% | — | |
| 35 | SLDB | Solid Biosciences Inc | Stock-Other | 0.40% | +0.10% | — | |
| 36 | DAWNGBX | Day One Biopharmaceuticals I | Stock-Other | 0.37% | — | +287.08% | |
| 37 | MDGL | Madrigal Pharmaceuticals Inc | Stock-Healthcare | 0.37% | +0.23% | — | |
| 38 | MSFT | Microsoft CORP | Stock-Tech | 0.33% | -0.03% | — | |
| 39 | HELP | Cybin Inc | Stock-Other | 0.33% | +0.29% | +109.69% | |
| 40 | VERA | Vera Therapeutics Inc | Stock-Other | 0.30% | -0.03% | +30.00% | |
| 41 | CTVA | Corteva Inc | Stock-Materials | 0.30% | -0.01% | — | |
| 42 | KMB | Kimberly-clark CORP | Stock-Consumer Staples | 0.30% | — | — | |
| 43 | 6D8 | Dupont De Nemours Inc | Stock-Other | 0.30% | -0.10% | EXIT | |
| 44 | WVE | Wave Life Sciences Ltd. | Stock-Other | 0.27% | -0.05% | +125.00% | |
| 45 | IBB | Ishares Biotechnology ETF | ETF-Tech | 0.26% | — | +125.00% | |
| 46 | AAPL | Apple Inc | Stock-Tech | 0.26% | — | — | |
| 47 | MREO | Mereo Biopharma Group Pl-adr | Stock-Other | 0.25% | -0.06% | EXIT | |
| 48 | IBM | Intl Business Machines CORP | Stock-Tech | 0.24% | +0.01% | — | |
| 49 | KURA | Kura Oncology Inc | Stock-Other | 0.24% | +0.05% | — | |
| 50 | ALKS | Alkermes plc | Stock-Healthcare | 0.23% | +0.84% | -60.61% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | GOOG | Alphabet Inc-cl C | +2.8% | — | Unchanged |
| 2 | SNDX | Syndax Pharmaceuticals Inc | +1.9% | +21.32% | Add |
| 3 | CLMT | Calumet Inc | +1.1% | -13.74% | Trim |
| 4 | VRDN | Viridian Therapeutics Inc | +0.8% | +27.43% | Add |
| 5 | ✓ | Avadel Pharmaceuticals PLC ADR | +0.7% | -14.79% | Trim |
| 6 | TVTX | Travere Therapeutics Inc | +0.6% | — | Add |
| 7 | PTGX | Protagonist Therapeutics Inc | +0.5% | +3.75% | Add |
| 8 | RCUS | Arcus Biosciences Inc | +0.5% | +36.00% | Add |
| 9 | XERS | Xeris Biopharma Holdings Inc | +0.5% | -4.25% | Trim |
| 10 | JNJ | Johnson & Johnson | +0.5% | — | Add |
| 11 | ✓ | +0.4% | — | Add | |
| 12 | ATRC | Atricure Inc | +0.3% | +3.35% | Add |
| 13 | WVE | Wave Life Sciences Ltd. | +0.2% | +125.00% | Add |
| 14 | VERA | Vera Therapeutics Inc | +0.2% | +30.00% | Add |
| 15 | SLDB | Solid Biosciences Inc | +0.2% | — | Add |
| 16 | JPM | Jpmorgan Chase & Co | +0.2% | -2.91% | Trim |
| 17 | TECX | Tectonic Therapeutic Inc | +0.1% | — | Add |
| 18 | HELP | Cybin Inc | +0.1% | +109.69% | Add |
| 19 | MSFT | Microsoft CORP | +0.1% | — | Unchanged |
| 20 | CSX | Csx CORP | 0% | — | Unchanged |
| 21 | AVGO | Broadcom Inc | 0% | — | Unchanged |
| 22 | NVDA | Nvidia CORP | 0% | — | Unchanged |
| 23 | PWR | Quanta Services Inc | 0% | — | Unchanged |
| 24 | ✓ | 0% | — | Unchanged | |
| 25 | URI | United Rentals Inc | 0% | — | Unchanged |
| 26 | AAPL | Apple Inc | — | — | Unchanged |
| 27 | ✓ | — | — | Unchanged | |
| 28 | AMZN | Amazon.com Inc | — | — | Unchanged |
| 29 | EBC | Eastern Bankshares Inc | — | — | Unchanged |
| 30 | ✓ | — | — | Unchanged | |
| 31 | GME | GameStop Corp. | — | — | Unchanged |
| 32 | CRM | Salesforce Inc | — | — | Unchanged |
| 33 | AETUF | Arc Resources LTD | — | — | Unchanged |
| 34 | OXY | Occidental Petroleum CORP | — | — | Unchanged |
| 35 | KD | Kyndryl Holdings Inc | — | — | Unchanged |
| 36 | TMO | Thermo Fisher Scientific Inc | — | — | Unchanged |
| 37 | GEHC | GE Healthcare Technology | — | — | Unchanged |
| 38 | STWD | Starwood Property Trust Inc | — | — | Unchanged |
| 39 | WAB | Wabtec CORP | — | — | Unchanged |
| 40 | IBM | Intl Business Machines CORP | 0% | — | Unchanged |
| 41 | DOW | Dow Inc | 0% | — | Unchanged |
| 42 | TTEN | Totalenergies Se -spon Adr | 0% | — | Unchanged |
| 43 | DHR | Danaher CORP | 0% | — | Unchanged |
| 44 | CNQ | Canadian Natural Resources | 0% | — | Unchanged |
| 45 | ABBV | Abbvie Inc | 0% | — | Unchanged |
| 46 | CTVA | Corteva Inc | 0% | — | Unchanged |
| 47 | 6D8 | Dupont De Nemours Inc | 0% | — | Unchanged |
| 48 | LLY | Eli Lilly & Co | 0% | — | Unchanged |
| 49 | LEGH | Legacy Housing CORP | 0% | — | Trim |
| 50 | BMY | Bristol-myers Squibb Co | -0.1% | — | Add |
According to official SEC Form 13F filings, Knott David M Jr reported a total U.S. public equity portfolio value of $189.2M across 88 disclosed positions in Q3 2025.
During Q3 2025, Knott David M Jr's top holdings by market value included CLMT (20.8%)、APO (12.1%)、GOOG (11.0%). The largest single position, CLMT, represented 20.8% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Top New Position Initiated
DAR
市值: $9.3M
Top Position Liquidated / Trimmed
ESGRP
前期市值: $2.5M
In Q3 2025, Knott David M Jr made 69 total portfolio adjustments, initiating 22 new buys, adding to 15 positions, trimming 14 holdings, and fully liquidating 18 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.